Author
Listed:
- Obi Kamsochukwu Ego
(National Association of Public Health Practitioners of Nigeria)
- Ojong Naomi Agbor
(National Association of Public Health Practitioners of Nigeria)
- Ola-Oluwa Samuel Ayomide
(National Association of Public Health Practitioners of Nigeria)
Abstract
This study investigates the actuarial implications of gene therapy and personalized medicine in cancer treatment in Anambra State, Nigeria. The research design was a descriptive survey, with 60 patients diagnosed with cancer from 20 general hospitals in Anambra State selected using purposive sampling. The questionnaire, titled “Questionnaire on Actuarial Implications of Gene Therapy and Personalized Medicine for Cancer Treatment†(QAIGPMCT), was structured and validated. The Cronbach Alpha Method was used to determine internal consistency and descriptive statistics of mean were used to answer the research questions posed. The findings revealed that patients in Anambra State, Nigeria, agreed on the cost-effectiveness of implementing personalized medicine and gene therapy for cancer treatment. They also noted that these treatments positively impacted financial outcomes for both patients and healthcare providers. Insurance policies and actuarial risk assessments were also influenced by these treatments. The study suggests that actuaries should assess financial risks associated with personalized medicine and gene therapy, considering factors like treatment effectiveness uncertainty, cost fluctuations, and reimbursement policy changes.
Suggested Citation
Obi Kamsochukwu Ego & Ojong Naomi Agbor & Ola-Oluwa Samuel Ayomide, 2024.
"Assessing the Actuarial Implications of Gene Therapy and Personalized Medicine in Nigeria: A Case Study of Cancer Treatment,"
International Journal of Research and Scientific Innovation, International Journal of Research and Scientific Innovation (IJRSI), vol. 11(15), pages 139-146, August.
Handle:
RePEc:bjc:journl:v:11:y:2024:i:15:p:139-146
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bjc:journl:v:11:y:2024:i:15:p:139-146. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dr. Renu Malsaria (email available below). General contact details of provider: https://rsisinternational.org/journals/ijrsi/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.